CDKN2A and acute lymphoblastic leukemia: These in vivo studies might reflect our findings, since most T-ALL cases characterized as CD4/CD8 DP had IL7Rmut and NOTCH1mut (81.2%), while CDKN2A/B and LEF1 deletions by contrast, were rarely found in our ETP-ALL cohort.